Back to ABTView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Exocrine Pancreatic Insufficiency, Chronic Pancreatitis
View Full LandscapeDrug Information
Target Indication
Exocrine Pancreatic Insufficiency, Chronic Pancreatitis
Clinical Trial
NCT00400842Last updated: 1/7/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
lopinavir/ritonavir (LPV/r) tablet with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)Phase 3
Human Immunodeficiency Virus Infections
Creon®Phase 3
Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
Phleum pratense grass pollen allergen extractPhase 3
Seasonal Allergic Rhinitis
Niacin ER/Simvastatin TabletsPhase 3
Hyperlipidemia
cefdinirPhase 3
Acute Otitis Media
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts